Anika Therapeutics Inc (ANIK) Stock Price, Quote & AI Analysis

Live ANIK stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Anika Therapeutics Inc.

TradeVae provides AI-driven analysis and real-time market intelligence for Anika Therapeutics Inc (ANIK), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

ANIK
Anika Therapeutics Inc
real-time
$0.00 +0.00 (+0.00%)
Open
10.400000
High
10.540000
Low
10.330000
Volume
12,459
VWAP
-
Market Cap
$153,874,406.73
52W Range
$7.87 - $18.35
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 10, 2026 Q4
After Hours
EPS Estimate: $-0.2193
Revenue Estimate: $29,452,500.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Anika Therapeutics Inc's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Anika Therapeutics Inc Overview

Company information

Company Overview

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Company Details
Market Cap
$150.20M
Shares Outstanding
14,421,200
Weighted Shares Outstanding
14,421,219
CEO
Stephen D. Griffin
Address
32 WIGGINS AVENUE, BEDFORD, MA, 01730
Employees
288
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Anika Therapeutics Inc Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...